The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...

Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...

THE King attended his first public engagement since his short hospital stay following cancer treatment side effects. Charles presided over an investiture ceremony at Windsor Castle where he ...

However, another common location for breast cancer to spread is the bone marrow ... One of the first symptoms of prostate cancer is sometimes anemia. Additionally, anemia occurs frequently with ...

"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every ...

On March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate cancer pre-chemotherapy. Just six days ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone and with other drug combinations. The FDA has approved the use of Gozellix, a ...